Bioiberica is pleased to announce a new strategic partnership with STAUBER, a leading US nutraceutical ingredients distributor. As one of the largest and fastest growing regions for health and wellness solutions, the US is a top priority for Bioiberica. Effective from 1 January 2025, the STAUBER collaboration will supercharge the reach of Bioiberica’s science-backed, branded ingredients for mobility and beauty-from-within, solidifying the company’s foothold in the booming US nutraceuticals market and driving innovation in the sector to support the wellbeing of millions of American consumers.
With over 100 years of combined expertise in health ingredients and the science of wellbeing, Bioiberica and STAUBER form the ultimate team to fuel US supplement innovation. Founded just six years apart – Bioiberica in 1975 and STAUBER in 1969 – both companies bring decades of experience, an unshakable commitment to quality and shared passion for sustainable practices, while contributing unique strengths to this powerhouse partnership.
“The US plays a pivotal role in our growth strategy, offering unparalleled opportunities to advance innovation and meet rising consumer demand for science-backed health solutions. However, succeeding in this dynamic market requires more than a presence – it demands solid collaboration,” comments Joan Bassa, Director of Human Health at Bioiberica. “Our union with STAUBER goes beyond a distribution agreement – it’s a bold commitment to connect with and empower American supplement manufacturers and advance the field of nutraceutical science through the power of true partnership.”
Shirley Rozeboom, Vice President of Health & Nutrition at STAUBER, adds, "The unique Bioiberica products enhance our portfolio, particularly in beauty, joint, and muscle wellness. We are honoured to represent these science-driven ingredients for health and longevity. We look forward to meeting the diverse needs of our customers and industry markets."
Bioiberica’s branded ingredients portfolio features some of the most unique and on-trend functional health solutions available to today’s supplement producers. This includes its trusted native (undenatured) type II collagen ingredient, Collavant® n2 (40 mg/day) for joint health, as well as industry-first hyaluronic acid matrix ingredients, Mobilee® (80 mg/day) for muscle and joint support and Dermial® (60mg/day) for skin and beauty. Backed by robust science and exciting new research – including two fresh clinical studies further demonstrating the benefits of Collavant® n2 for joint health, a breakthrough trial demonstrating the ‘glow’ effect of Dermial® and new in-vitro data on Mobilee® for muscle health – these branded ingredients will enable supplement producers to carve out their share of the $160 billion (and growing) US nutraceuticals market.[1]
[1] Precedence Research, U.S. Nutraceuticals Market Size, Share, and Trends 2024 to 2033, February 2024, https://www.precedenceresearch.com/us-nutraceuticals-market